SCHEMBL7569208

SCHEMBL7569208

Clc1ccc(-c2cnc(Nc3ccccn3)s2)cc1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 19/20 0.78
CNR1 P21554 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179920 0.88 KDR (1.00) KDR
SCHEMBL6179560 0.86 KDR (0.78) KDR
SCHEMBL6182098 0.82 KDR (0.72) KDR
SCHEMBL13701560 0.81 KDR (0.81) KDR
SCHEMBL7237283 0.81 KDR (1.00) KDRCNR1
SCHEMBL6178573 0.81 KDR (0.70) KDR
SCHEMBL7490947 0.81 KDR (0.79) KDR
SCHEMBL7487695 0.80 KDR (0.65) KDR
SCHEMBL6180047 0.80 KDR (0.77) KDR
SCHEMBL6179228 0.79 KDR (0.72) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218376-A4 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2002-11-20 EP disclosed
EP-1218376-A1 TYROSINE KINASE INHIBITORS Merck & Co., Inc. (US) 2002-07-03 EP disclosed
WO-2001017995-A1 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2001-03-15 WO disclosed